Comments
Loading...

Cognition Therapeutics (CGTX) Stock Price, Quote, News & History

CGTXNASDAQ
Logo brought to you by Benzinga Data
$1.66
-0.03-1.78%
Last update: Dec 15, 9:58 AM
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

1
Jun
1
Aug
2
Nov
1
Dec
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
$1.70
Close
-
Volume / Avg.
88.83K / 1.80M
Day Range
$1.66 - $1.71
52 Wk Range
0.22 - 3.83
Market Cap
$146.54M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
50
Short Interest
7.8%
Days to Cover
6.9

About

Sector
Health Care
Industry
Pharmaceuticals
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its ...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CGTX
AVIR

FAQ

Q

How do I buy Cognition Therapeutics (CGTX) stock?

A

You can purchase shares of Cognition Therapeutics (NASDAQ:CGTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cognition Therapeutics (CGTX) competitors?

Q

What is the forecast, or price target, for Cognition Therapeutics (CGTX) stock?

A

Cognition Therapeutics has a consensus price target of $5.79.

Q

What is the current price for Cognition Therapeutics (CGTX)?

A

The stock price for Cognition Therapeutics (NASDAQ: CGTX) is $1.66 last updated December 15, 2025 at 9:58 AM EST.

Q

Does Cognition Therapeutics (CGTX) pay a dividend?

A

There are no upcoming dividends for Cognition Therapeutics.

Q

When is Cognition Therapeutics (NASDAQ:CGTX) reporting earnings?

A

Cognition Therapeutics does not have any upcoming earnings scheduled.

Q

Is Cognition Therapeutics (CGTX) going to split?

A

There is no upcoming split for Cognition Therapeutics.

Q

What sector and industry does Cognition Therapeutics (CGTX) operate in?

A

Cognition Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.